Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Similar articles for PubMed (Select 23696705)

1.

Magnetic resonance spectroscopy in Alzheimer's disease.

Graff-Radford J, Kantarci K.

Neuropsychiatr Dis Treat. 2013;9:687-96. doi: 10.2147/NDT.S35440. Epub 2013 May 16.

2.

In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.

Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1313-22.

PMID:
15588758
4.

Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.

Weiss U, Bacher R, Vonbank H, Kemmler G, Lingg A, Marksteiner J.

J Clin Psychiatry. 2003 Mar;64(3):235-42.

PMID:
12716263
5.
6.

Proton magnetic resonance spectroscopy of the brain in dementia.

De Stefano N, Mortilla M, Federico A.

Ital J Neurol Sci. 1999;20(5 Suppl):S258-64. Review.

PMID:
10662965
7.

Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment.

Griffith HR, Stewart CC, den Hollander JA.

Int Rev Neurobiol. 2009;84:105-31. doi: 10.1016/S0074-7742(09)00406-1. Review.

PMID:
19501715
8.

Proton magnetic resonance spectroscopy in Alzheimer's disease, a review.

Loos C, Achten E, Santens P.

Acta Neurol Belg. 2010 Dec;110(4):291-8. Review.

PMID:
21305856
9.

Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.

Mosconi L, De Santi S, Rusinek H, Convit A, de Leon MJ.

Expert Rev Neurother. 2004 Sep;4(5):831-49. Review.

PMID:
15853510
10.

Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.

García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.

Dement Geriatr Cogn Disord. 2008;26(1):15-25. doi: 10.1159/000140624. Epub 2008 Jun 20.

PMID:
18566544
11.

[Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].

Martínez-Bisbal MC, Arana E, Martí-Bonmatí L, Martínez-Granados B, Celda B.

Radiologia. 2006 Sep-Oct;48(5):301-7. Spanish.

12.

Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging.

Watanabe T, Shiino A, Akiguchi I.

Dement Geriatr Cogn Disord. 2010;30(1):71-7. doi: 10.1159/000318750. Epub 2010 Aug 5.

14.

"Brain-specific" nutrients: a memory cure?

McDaniel MA, Maier SF, Einstein GO.

Nutrition. 2003 Nov-Dec;19(11-12):957-75. Review.

PMID:
14624946
15.

Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.

Catani M, Mecocci P, Tarducci R, Howard R, Pelliccioli GP, Mariani E, Metastasio A, Benedetti C, Senin U, Cherubini A.

J Am Geriatr Soc. 2002 Oct;50(10):1707-10.

PMID:
12366626
16.

1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease.

Parnetti L, Lowenthal DT, Presciutti O, Pelliccioli GP, Palumbo R, Gobbi G, Chiarini P, Palumbo B, Tarducci R, Senin U.

J Am Geriatr Soc. 1996 Feb;44(2):133-8.

PMID:
8576501
17.

Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly.

Moore CM, Frederick BB, Renshaw PF.

J Geriatr Psychiatry Neurol. 1999 Fall;12(3):107-17. Review.

PMID:
10593699
18.

Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease.

Kantarci K.

Expert Rev Neurother. 2005 Sep;5(5):663-70. Review.

PMID:
16162090
19.

A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.

den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, Niessen WJ, Breteler MM.

Brain. 2010 Apr;133(Pt 4):1163-72. doi: 10.1093/brain/awq048.

20.

Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias.

Scheltens P, Korf ES.

Curr Opin Neurol. 2000 Aug;13(4):391-6. Review.

PMID:
10970055
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk